Skip to main content
. 2016 Nov 22;6(4):45. doi: 10.3390/biom6040045

Figure 2.

Figure 2

Number of differentially methylated genomic loci across cancers: (A) Figure generated using data from [62]. The vertical axis represents total count. For each cancer, the differentially methylated CpGs were defined as those with average methylation levels above 25% in tumors and less than 5% in controls; (B) Figure generated using data from [62]. The horizontal axis represents the number of features (either differentially methylated CpGs or genes that contain differentially methylated CpGs) that are shared by a number of cancer types that is greater than or equal to the value shown in the vertical axis. COAD: colon adenocarcinoma; LUAD: lung adenocarcinoma; BRCA: breast invasive carcinoma; PAAD: pancreatic adenocarcinoma; UCEC: uterine corpus endometrial carcinoma; HNSC: head and neck squamous cell carcinoma; READ: rectum adenocarcinoma; LUSC: lung squamous cell carcinoma; STAD: stomach adenocarcinoma; LIHC: liver hepatocellular carcinoma; PRAD: prostate adenocarcinoma; BLCA: bladder urothelial carcinoma; KIRC: kidney renal clear cell carcinoma; KIRP: kidney renal papillary cell carcinoma.